Down-regulation of the microRNAs miR-34a, miR-127, and miR-200b in rat liver during hepatocarcinogenesis induced by a methyl-deficient diet

Molecular Carcinogenesis

Volumn 48, Issue 6, 2009, Pages 479-487

  Tryndyak, Volodymyr P ^a   Ross, Sharon A ^b   Beland, Frederick A ^a   Pogribny, Igor P ^a  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Apoptosis; Hepatocarcinogenesis; microRNAs; p53

Indexed keywords

CHOLINE; FOLIC ACID; METHIONINE; METHYL GROUP; MICRORNA; NOTCH1 RECEPTOR; PROTEIN BCL 2; PROTEIN BCL 6; TRANSCRIPTION FACTOR E2F3;

ALCOHOL CONSUMPTION; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER GROWTH; CELL ADHESION; CELL PROLIFERATION; CELL TRANSFORMATION; CONTROLLED STUDY; DOWN REGULATION; EPITHELIUM CELL; GENE; GENE DISRUPTION; GENE EXPRESSION; GENE REPRESSION; GENE TARGETING; GENETIC TRANSFECTION; HEPATITIS B; HEPATITIS C; HISTOPATHOLOGY; LIVER CARCINOGENESIS; MALE; MESENCHYME CELL; METABOLIC REGULATION; MIR 127; MIR 200B; MIR 34A; NONHUMAN; NUTRITIONAL DEFICIENCY; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; DIET; DOWN-REGULATION; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MICRORNAS; RATS; RATS, INBRED F344; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

HEPATITIS C VIRUS; RATTUS;

EID: 65749109370     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20484     Document Type: Article

References (56)

1. Bartel DP. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 2004;116:281-297. (Pubitemid 38167318)
2. Sevignani C, Calin GA, Siracusa LD, Croce CM. Mammalian microRNAs: A small world for fine-tuning gene expression. Mamm Genome 2006;17:189-202.
3. Bushati N, Cohen SM. microRNAs functions. Annu Rev Cell Dev Biol 2007;23:175-205.
4. Hwang H-W, Mendell JT. MicroRNAs in cell proliferation, cell death, and tumorigenesis. Br J Cancer 2006;94:776-780.
5. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100:57-70. (Pubitemid 30046295)
6. Evan GI, Vousden KH. Proliferation, cell cycle and apoptosis in cancer. Nature 2001;411:342-348.
7. Calin GA, Dumitru CD, Shimizu M, et al. Frequent deletions and down-regulation of microRNA genes miR15 and miR16 at 13q14 in chronic lymphatic leukemia. Proc Natl Acad Sci USA 2002;99:15524-15529.
8. Lu J, Getz G, Miska EA, et al. MicroRNA expression profiles classify human cancers. Nature 2005;435:834-838.
9. Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006;6:857-866. (Pubitemid 44629897)
10. Murakami Y, Yasuda T, Saigo K, et al. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene 2006;25:2537-2545.
11. Gramantieri L, Ferracin M, Fornari F, et al. Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. Cancer Res 2007; 67:6092-6099.
12. Hammond SM. MicroRNAs as oncogenes. Curr Opin Genet Dev 2006;16:4-9. (Pubitemid 43089605)
13. Kent OA, Mendell JT. A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes. Oncogene 2006;25:6188-6196. (Pubitemid 44527849)
14. Zhang B, Pan X, Cobb GP, Anderson TA. microRNAs as oncogenes and tumor suppressors. Dev Biol 2007;302:1-12. (Pubitemid 46096921)
15. Kumar MS, Lu J, Mercer KL, Golub TR, Jacks T. Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat Genet 2007;39:673-677. (Pubitemid 46676103)
16. Farazi PA, DePinho RA. Hepatocellular carcinoma pathogenesis: From genes to environment. Nat Rev Cancer 2006;6:674-687.
17. Thorgeirsson SS, Grisham JW. Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet 2002;31:339-346. (Pubitemid 35154440)
18. Lee JS, Chu IS, Mikaelyan A, et al. Application of comparative functional genomics to identify best-fit mouse model to study human cancer. Nat Genet 2004;36:1306-1311.
19. Nakae D. Endogenous liver carcinogenesis in the rat. Pathol Int 1999;49:1028-1042. (Pubitemid 30193501)
20. Powell CL, Kosyk O, Bradford BU, et al. Temporal correlation of pathology and DNA damage with gene expression in a choline-deficient model of rat liver injury. Hepatology 2005;42:1137-1147.
21. Kutay H, Bai S, Datta J, et al. Downregulation of miR-122 in the rodent and human hepatocellular carcinomas. J Cell Biochem 2006;99:671-678.
22. Kimura SH, Nojima H. Cyclin G1 associates with MDM2 and regulates accumulation and degradation of p53 protein. Gen Cells 2002;7:869-880.
23. Hussain SP, Schwank J, Staib F, Wang XW, Harris CC. TP53 mutations and human hepatocellular carcinoma: Insights into the etiology and pathogenesis of liver cancer. Oncogene 2007;26:2166-2176.
24. Pitot HC. Adventures in hepatocarcinogenesis. Annu Rev Pathol 2007;2:1-29. (Pubitemid 46448058)
25. -ΔΔCt method. Methods 2001;25:402-408.
26. Zhao CQ, Young MR, Diwan BA, Coogan TP, Waalkes MP. Association of arsenic-induced malignant transformation with DNA hypomethylation and aberrant gene expression. Proc Natl Acad Sci USA 1997;94:10907-10912. (Pubitemid 27430834)
27. James SJ, Miller BJ, Basnakian AG, Pogribny IP, Pogribna M, Muskhelishvili L. Apoptosis and proliferation under conditions of deoxynucleotide pool dysbalance in liver of folate/methyl deficient rats. Carcinogenesis 1997;18:287-293. (Pubitemid 28132420)
28. Pogribny IP, Muskhelishvili L, Miller BJ, James SJ. Presence and consequence of uracil in preneoplastic DNA from folate/methyl-deficient rats. Carcinogenesis 1997;18: 2071-2076. (Pubitemid 28134731)
29. Esfandiari F, Green R, Cotterman RF, Pogribny IP, James SJ, Miller JW. Methyl deficiency causes reduction of the methyl-CpG-binding protein, MeCP2, in rat liver. Carcinogenesis 2003;24:1935-1940. (Pubitemid 38008534)
30. INK4A gene in early preneoplastic liver and tumors induced by folate/methyl deficiency in rats. Cancer Lett 2002;187:69-75.
31. Welch C, Chen Y, Stallings RL. MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells. Oncogene 2007;26:5017-5022. (Pubitemid 47172643)
32. Tazawa H, Tsuchiya N, Izumiya M, Nakagama H. Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells. Proc Natl Acad Sci USA 2007;104:15472-15477. (Pubitemid 47502941)
33. Fukuda Y, Kawasaki H, Taira K. Exploration of human miRNA target genes in neuronal differentiation. Nucleic Acid Symp Ser 2005;49:341-342.
34. Cimmino A, Calin GA, Fabbri M, et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci USA 2005;102:13944-13949. (Pubitemid 41377683)
35. Saito Y, Liang G, Egger G, et al. Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell 2006;9:435-443.
36. Pekarsky Y, Santanam U, Cimmino A, et al. Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181. Cancer Res 2006;66:11590-11593.
37. Christoffersen NR, Silahtaroglu A, Orom UA, Kauppinen S, Lund AH. miR-200b mediates post-transcriptional repression of ZFHX1B. RNA 2007;13:1172-1178. (Pubitemid 47080461)
38. O'Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT. c-Myc-regulated microRNAs modulate E2F1 expression. Nature 2005;435:839-843. (Pubitemid 40839736)
39. Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, Patel T. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 2007;133:647-658. (Pubitemid 47187346)
40. Asangani IA, Rasheed SA, Nikolova DA, et al. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 2008;27:2128-2136.
41. Johnson CD, Esquela-Kersher A, Stefani G, et al. The let-7 microRNA represses cell proliferation pathways in human cells. Cancer Res 2007;67:7713-7722.
42. Pogribny IP, Ross SA, Wise C, et al. Irreversible global DNA hypomethylation as a key step in hepatocarcinogenesis induced by dietary methyl deficiency. Mut Res 2006;593:80-87.
43. Pogribny IP, Miller BJ, James SJ. Alterations in hepatic p53 gene methylation patterns during tumor progression with folate/methyl deficiency in the rat. Cancer Lett 1997;115:31-38. (Pubitemid 27139853)
44. Hurteau GJ, Carlson JA, Spivack SD, Brock GJ. Overexpression of microRNA has-miR-200c leads to reduced expression of transcription factor 8 and increased expression of E-cadherin. Cancer Res 2007;67:7972-7976. (Pubitemid 47395127)
45. Vanderwalle C, Comijin J, De Craene B, et al. SIP1/ZEB2 induces EMT by repressing genes of different epithelial cell-cell junctions. Nucl Acid Res 2005;33:6566-6578.
46. He L, He X, Lim LP, et al. A microRNA component of the p53 tumour suppressor network. Nature 2007;447:1130-1135.
47. Hermeking H. p53 enters the microRNA world. Cancer Cell 2007;12:414-418.
48. Wu L, Timmers C, Maiti B, et al. The E2F1-3 transcription factors are essential for cellular proliferation. Nature 2001;414:457-462.
49. CIP1 axis by E2f1, E2f2, and E2F3 is essential for G1/S progression and cellular transformation. J Biol Chem 2006;281:36124-36131.
50. Ginsberg D. E2F3 - A novel repressor of the ARF/p53 pathway. Dev Cell 2004;6:742-743. (Pubitemid 38745406)
51. Paulson QX, McArthur MJ, Johnson DG. E2F3a stimulates proliferation, p53-independent apoptosis and carcinogenesis in a transgenic mouse model. Cell Cycle 2006;5:184-190. (Pubitemid 43131157)
52. Kim SB, Chae GW, Lee J, Park J, Tak H, Chung JH, Park TG, Ahn JK, Joe CO. Activated Notch1 interacts with p53 to inhibit its phosphorylation and transactivation. Cell Death Differ 2007;14:981-991. (Pubitemid 46629836)
53. Phan RT, Dalla-Favera R. The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells. Nature 2004;432:635-639. (Pubitemid 39626271)
54. Jiang J, Gusev Y, Aderca I, et al. Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival. Clin Cancer Res 2008;14:419-427.
55. Budhu A, Jia HL, Forgues M, et al. Identification of metastasis related microRNAs in hepatocellular carcinoma. Hepatology 2008;47:897-907.
56. Dragan YP, Pitot HC. The role of the stages on initiation and promotion in phenotypic diversity during hepatocarcinogenesis in the rat. Carcinogenesis 1992;13:739-750.